First Time Loading...
E

Evotec SE
XETRA:EVT

Watchlist Manager
Evotec SE
XETRA:EVT
Watchlist
Price: 8.4 EUR 0.72% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
Evotec SE?
Write Note

Evotec SE
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Evotec SE
Total Current Liabilities Peer Comparison

Comparables:
GXI
S
1SXP

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
E
Evotec SE
XETRA:EVT
Total Current Liabilities
€443m
CAGR 3-Years
23%
CAGR 5-Years
19%
CAGR 10-Years
29%
Gerresheimer AG
XETRA:GXI
Total Current Liabilities
€973.2m
CAGR 3-Years
19%
CAGR 5-Years
7%
CAGR 10-Years
9%
S
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Total Current Liabilities
€351.1m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Evotec SE's Total Current Liabilities?
Total Current Liabilities
443m EUR

Based on the financial report for Mar 31, 2024, Evotec SE's Total Current Liabilities amounts to 443m EUR.

What is Evotec SE's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
29%

Over the last year, the Total Current Liabilities growth was 31%. The average annual Total Current Liabilities growth rates for Evotec SE have been 23% over the past three years , 19% over the past five years , and 29% over the past ten years .